Vaccine Therapy in Treating Patients With Metastatic Melanoma
NCT00087373
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
28
Enrollment
NIH
Sponsor class
Conditions
Recurrent Melanoma
Stage IV Melanoma
Interventions
BIOLOGICAL:
recombinant fowlpox-TRICOM vaccine
OTHER:
laboratory biomarker analysis
Sponsor
National Cancer Institute (NCI)